Human equilibrative nucleoside transporter 1 testing in pancreatic ductal adenocarcinoma: a comparison between murine and rabbit antibodies

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|66|3|457-462

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.66, Iss.3, 2015-02, pp. : 457-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 19, Iss. 6, 2012-11 ,pp. : 717-722

John Wiley & Sons Inc

Access to resources Recommend Favorite

Erratum to: Human equilibrative nucleoside transporter 1 level does not predict prognosis in pancreatic cancer patients treated with neoadjuvant chemoradiation including gemcitabine

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 19, Iss. 6, 2012-11 ,pp. : 723-723

John Wiley & Sons Inc

Access to resources Recommend Favorite

Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 23, Iss. 9, 2016-09 ,pp. : 523-532

John Wiley & Sons Inc

Access to resources Recommend Favorite

Inhibition of Ankyrin-B Expression Reduces Growth and Invasion of Human Pancreatic Ductal Adenocarcinoma

By  

Pancreatology, Vol. 10, Iss. 5, 2010-10 ,pp. : 586-596

Karger

Access to resources Recommend Favorite

Evaluation of a Novel Anti-Mucin 1 (MUC1) Antibody (PankoMab) as a Potential Diagnostic Tool in Human Ductal Breast Cancer; Comparison with Two Established Antibodies

By  

Oncology Research and Treatment, Vol. 32, Iss. 5, 2009-04 ,pp. : 238-244

Karger

Access to resources Recommend Favorite